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http://dxObjectives: This study evaluated the effect of high selective bilateral vagotomy of hilus pulmonis with
video-assisted thoracoscopy on asthma.
Methods: Eight dogs with skin sensitive to Ascaris suum antigens were randomly divided into groups A and B.
Asthma was induced by aerosol inhalation of A suum antigens. Respiratory rate and peak airway pressure were
significantly increased (P<.05) in both groups. Dynamic compliance was dramatically increased (P<.05) in
both groups. Two days later, bilateral vagotomy of hilus pulmonis under thoracoscopic guidance was performed
on dogs in group A; dogs in group B underwent bilateral sham vagotomy plus thoracoscopy. Five days after
treatment, all dogs had rechallenge with a second aerosol inhalation.
Results: Dogs in group A did not show typical asthmatic symptoms, and no significant changes were found in
respiratory rate, peak airway pressure, and dynamic compliance (P>.05). Dogs in group B still had typical
symptoms, and respiratory rate and peak airway pressure were increased and dynamic compliance decreased
significantly (P<.05 for all). Significant differences in respiratory rate, peak airway pressure, and dynamic
compliance were observed between groups. Moreover, inflammatory cells in the lungs and bronchoalveolar
lavage fluid of group A were dramatically reduced relative to group B (P< .05). There were no significant
changes in heart rate and mean arterial pressure after vagotomy, indicating that vagotomy did not affect the
cardiac plexus of vagus.
Conclusions: High selective bilateral vagotomy of hilus pulmonis with thoracoscope can effectively control
asthma in dogs. (J Thorac Cardiovasc Surg 2014;148:683-9)E
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SAsthma is a condition characterized by chronic inflamma-
tion, bronchial hyper-responsiveness, and reversible airway
obstruction and was reported to affect 300 million people.
In some parts of the world, about 30% of people with
asthma are children,1,2 and the asthma-related medical
care cost is more than that of AIDS and tuberculosis
combined.3
During the past decade, advances in the treatment of
asthma have been modest at most.4 Prospective studies
have shown that approximately 30% of patients with asthma
did not have good control with standard therapy consisting
of corticosteroids and b2-adrenoreceptor agonists.
5 Tio-
tropium bromide, a long-acting anticholinergic inhalant,
was recently demonstrated to be potentially useful for
uncontrolled asthma when used in combination with the
standard therapy.6-8 The finding suggested that vagal
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The Journal of Thoracic and Caprocess of asthma. Elevated vagal tone was found to be
associated with airway hyperresponsiveness resulting from
stimulation of the airway smooth muscles and mucous
bronchial glands. Mediated through the parasympathetic
nerve pathway, reflex bronchoconstriction is induced by
proinflammatory chemical mediators.9 Some side effects,
such as dry mouth, have been reported in patients with
asthma who are taking anticholinergic drugs.6 This promp-
ted researchers to look into treating asthma by specifically
blocking the bronchial vagal pathway.
In fact, from 1957 to 1964, some studies showed that
asthma could be brought under control after vagotomy.10,11
Vagotomy, however, could not be used as a routine
treatment for asthma because traditional thoracotomy was
associated with a number of severe complications,
protracted hospital stay, and uncertainty of vagal excision
site. With the development of video-assisted thoracoscopic
surgery, the risk of thoracotomy was substantially
reduced,12-14 thus rendering surgical blockade of vagal
pathway clinically feasible.
In this study, we bilaterally cut off branches of hilus pul-
monis of asthmatic dogs under thoracoscopic guidance to
observe the effect on controlling asthma in an attempt to
provide a new treatment alternative for asthma.
MATERIALS AND METHODS
Animals
All animal studies were approved and conducted in strict accordance
with the guidelines of the institutional animal care and use committee.rdiovascular Surgery c Volume 148, Number 2 683
Abbreviations and Acronyms
Cdyn ¼ dynamic compliance
HR ¼ heart rate
HSVHP ¼ high selective bilateral vagotomy of the
hilus pulmonis
MAP ¼ mean arterial pressure
Ppeak ¼ peak airway pressure
RR ¼ respiratory rate
VT ¼ tidal volume
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SDomestic male dogs were acquired and housed in the Animal Center of
Medical College of Sun Yat-sen University. Eight dogs, weighing 15 kg
on average and with positive Ascaris suum antigen skin tests, were assigned
to 2 groups of 4 dogs each. Group A underwent high selective bilateral
vagotomy of the hilus pulmonis (HSVHP) with video-assisted thoraco-
scopy and group B underwent sham bilateral vagotomy with video-
assisted thoracoscopy.
Antigen Sensitization and Challenge
As previously described,15 all the dogs were subjected to A suum anti-
gen skin tests, and 8 dogs were found to have positive test results. The
dogs with positive results (Figure 1, A) were first challenged with aerosol
inhalation of A suum antigen (1%, for 5 minutes) by tracheal intubation.
After the operation, the dogs were challenged with a second aerosol
inhalation of A suum antigen (1%, for 5 minutes).
Surgical Procedures
Two days after the first challenges, dogs were kept on an overnight fast.
The next morning, the animals were anaesthetized with a ketamine (20
mg/kg) and xylazine (2 mg/kg) solution, and anesthesia was maintained
with inhalational isoflurane. The dogs were intubated and continuously
ventilated, with a tidal volume of 200 to 250 mL. Single-lung ventilation
was achieved with a bronchial blocker (Cook Medical Inc, Bloomington,
Ind). The PaO2 and heart rate (HR) were monitored by pulse oximetry
(Surgivet; Smiths Medical PM, Waukesha, Wis).
For the right-sided operation, the dogs were secured in the left lateral
decubitus position. The first port was placed in the right fifth intercostal
space, 4 cm from the spinal processes, and the second port was placed in
the right seventh intercostal space on the midaxillary line. The second
port was used for the camera. After the camera was introduced, the surgical
instruments were inserted under direct vision through the first port. Video-
assisted thoracoscopic surgery was performed with the LTF-240 scope
(I Olympus Optical Co Ltd; Tokyo, Japan). Topographically, on the right
side, the vagus nerve gives off 2 to 3 branches above the azygos vein
arch to the carina tracheae. The main trunk continuously descends behind
the root of the lung and supplies 7 to 8 branches along the posterior surface
of the right bronchia, forming the vagal pulmonary plexus. We dissociated
vagus nerve along the trachea, azygos vein arch, and right main bronchus
and then cut off the pulmonary plexus in group A dogs (Figure 1, B),
whereas the group B dogs only underwent sham thoracoscopic surgery,
with the vagus nerve left intact.
For the left-sided surgery, the dogs were placed in the right lateral decu-
bitus position. Another 2 ports were placed in the corresponding places of
the left side for introducing instruments and camera. At the inferior border
of the aortic arch, the main trunk of the vagus nerve gives off the left recur-
rent laryngeal nerve and 1 to 2 cardiac branches, and behind the root of lung
the main trunk it descends along the posterior surface of the left bronchus,
providing 4 to 5 branches to form the vagal pulmonary plexus (Figure 1,C).
In group A, we dissociated vagus nerve along trachea, aortic arch, and684 The Journal of Thoracic and Cardiovascular Surgesophagus (Figure 1, D) and then cut off pulmonary plexus on group A
while sham thoracoscopic surgery was performed in group B (Figure 1, E).
Lung Function and Hemodynamic Index
Respiratory rate (RR), peak airway pressure (Ppeak), dynamic compli-
ance (Cdyn), tidal volume (VT), HR, and mean arterial pressure (MAP)
were recorded 5 minutes before and 5 and 30 minutes after each challenge.
Pulmonary inflation pressure was measured through a sidearm of the
tracheal cannula. Bronchoconstriction was measured in terms of the in-
crease in the pulmonary inflation pressure above the basal inflation pressure
produced by the ventilator.
Arterial Blood Gas Analysis and Proinflammatory
Serum Markers
Arterial blood was collected from the femoral artery. PaO2, PaCO2, IgE,
and interleukin 4 (IL-4) were determined 5 minutes before and after each
challenge.
Bronchoalveolar Lavage Analysis
After the second challenge, the lungs were lavaged with 5 10-mL ali-
quots of warm phosphate-buffered saline solution containing 100-mmol/L
isoproterenol (Sigma-Aldrich Corporation, St Louis, Mo) in situ through
the tracheal cannula. Recovered lavage fluid was centrifuged, cells were
resuspended in phosphate-buffered saline solution, and total cells were
counted with a hemocytometer. Aliquots of the cell suspension were centri-
fuged, put onto glass slides, and stained for differential analysis.
Statistical Analysis
Data were expressed as mean  SD and analyzed with the SPSS
statistical software package (version 11.5; IBM Corporation, Armonk,
NY). Differences between groups were assessed with the Student t test.RESULTS
Successful Establishment of Canine AsthmaticModel
No significant differences were found between the groups
5 minutes before the first challenge with A suum antigen
(P> .05) in indices of lung function and arterial blood
gas analysis (Figure 2).
After the first challenge, all dogs showed typical symp-
toms of asthma, such as tachypnea, breathlessness, chest
tightness, and tongue cyanosis. Reinforced breath sounds
and wheezing rale could be heard during the attack. In addi-
tion, 5 minutes after the challenge, dogs in both groups
exhibited a significant increase in RR (Figure 2, A), with
the RR of group A increasing from 12  5.2 to 33  7.6
breaths/min (P<.05) and the RR of group B rising from 10
 3.6 to 40  9.0 breaths/min (P<.05). Similar changes in
Ppeak were observed in both groups (Figure 2, B), with the
Ppeak of group A increasing from 8  2.8 to 19  3.6 cm
H2O (P<.05) and the Ppeak of group B rising from 8  3.2
to 18 4.5 cmH2O (P<.05). Cdynwas dramatically reduced
in both groups (Figure 2,C), with Cdyn in groupA decreasing
from 38.5 9.5 to 11.1 5.0mL/cmH2O (P<.05) andCdyn
in group B dropping from 37 4.1 to 9.8 3.4 mL/cm H2O
(P< .05). VT in both groups showed a descending trend
(Figure 2, D), with VT in group A decreasing from 266 
99.6 to 208  91.9 mL (P > .05) and VT in group Bery c August 2014
FIGURE 1. A, Ascaris suum antigen skin test positive result. B, The right main trunk gives off branches along the posterior surface of the right bronchia,
forming the pulmonary plexus. The red arrow indicates the vagal main trunk, and thewhite arrow shows the branches forming the pulmonary plexus. C, The
left main trunk of the vagus nerve provides 4 to 5 branches to form the vagal pulmonary plexus. The red arrow indicates the vagal trunk, and thewhite arrow
shows the branches. D, Video-assisted thoracoscopy was performed for blunt dissection of the left trunk of the vagus nerve behind the root of the lung. The
white arrow shows the main trunk of the vagus nerve. E, Flowchart of the investigation process. VAT, Video-assisted thoracoscopy; HSVHP, high selective
bilateral vagotomy of the hilus pulmonis.
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Sdropping from 317 120.0 to 193 97.8 mL (P>.05). PaO2
in both groups was substantially reduced (Figure 2, E), PaO2
in group A dropped from 96  13.5 to 65  22.3 mm Hg
(P> .05) and PaO2 in group B dropped from 78  10.3 to
60 7.6 mm Hg (P<.05), whereas no significant difference
was found in PaCO2 (Figure 2,F), with PaCO2 in groupA rising
nonsignificantly from34 3.4 to 41.3 7.8mmHg (P>.05),
and PaCO2 in group B rising nonsignificantly from 37.2 8.4
to 37.7  8.5 mm Hg (P>.05).
The symptoms of dogs in both groups were relieved and
relevant indices returned to normal about 30 minutes after
the first challenges (Figure 2, A-D). The RR of group A
decreased to 19  7.3 breaths/min, and the RR of group
B to 17  4.5 breaths/min; the Ppeak of group A was
13  3.7 cm H2O, and the Ppeak of group B 11  5.0 cm
H2O; the Cdyn of group A was restored to 18.2  8.5
mL/cm H2O and the Cdyn of group B to 25.0  11.1
mL/cm H2O; the VT of group A was back to 245  109.8
mL/cm H2O and the VT of group B to 235  115.1 mL.
Relieving Effect of HSVHP on Airway
Hyperresponsiveness
The dogs of group A underwent HSVHP under thoraco-
scopic guidance, whereas the animals of group B wereThe Journal of Thoracic and Casubjected to a sham thoracoscopic surgery. Five days later,
the second challenge was delivered in both groups. Five
minutes before the second challenge, no differences were
found in indices of lung function and blood gas analysis
between the groups (Figure 3).
Five minutes after the second challenge, dogs in group A
showed no asthma-related symptoms, whereas the dogs of
group B still had typical asthmatic symptoms. In group A,
no significant change in RR was observed, whereas the
dogs in group B exhibited a substantial increase in RR
(Figure 3, A), with the RR of group B increasing from 12
 4.2 to 40  12.9 breaths/min (P< .05) and the RR of
group A increasing only nonsignificantly from 10  4.9
to 12  4.2 breaths/min (P>.05). There was a significant
difference in RR between the groups (P<.05). The Ppeak
in group A showed no significant change, whereas a great
increase in Ppeak was seen in group B (Figure 3, B), with
the Ppeak of group B increasing from 7  3.6 to 18  5.1
cm H2O (P< .05) and the Ppeak of group A increasing
only nonsignificantly from 8  3.1 to 10  3.1 cm H2O
(P> .05) and a significant difference between the groups
(P<.05) observed in Ppeak. The Cdyn in group A dropped
slightly, whereas in group B a significant decline was found
(Figure 3, C), with the Cdyn of group A decreasing fromrdiovascular Surgery c Volume 148, Number 2 685
FIGURE 2. Compared with indices 5 minutes before challenge, 5 minutes after the first challenge the airway reactivity indices such as respiratory rate
(RR; A), peak airway pressure (Ppeak; B) were increased remarkably (P<.05) in both groups. A dramatic decrease (P<.05) in dynamic compliance
(Cdyn; C) was observed in both groups. The tidal volume (VT; D) and PaO2 (E) showed a descending trend (P>.05) in both groups, whereas no significant
changes (P>.05) were found in PaCO2 (F). The indices were restored to normal about 30 minutes after the first challenges (A-D). 5 MBC, 5 minutes before
challenge; 5 MAC, 5 minutes after challenge; 30 MAC, 30 minutes after challenge.
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S36.7 8.5 to 34.7 9.5 mL/cmH2O (P>.05) and the Cdyn
of group B decreasing from 38.6 6.3 to 10.8 5.3 mL/cm
H2O (P< .05). There was also a significant difference in
Cdyn between the groups (P< .05). The VT in group B
decreased from 301  71.2 to 206  89.9 mL (P> .05),
whereas the VT of group A was increased from 275 
81.5 to 320  82.5 mL (P> .05; Figure 3, D). For PaO2,
no significant change was found in group A, whereas a dra-
matic drop was seen in group B (Figure 3, E), with the PaO2
of group B decreasing from 84 15.6 to 58  11.6 mm Hg
(P<.05) and the PaO2 of group A dropping from 81  13.7
to 73 13.8 mm Hg (P>.05). PaCO2 showed no significant
change in either group (Figure 3,F), with the PaCO2 of group
A dropping from 34.9 4.5 to 34.2 5.5 mm Hg (P>.05)
and the PaCO2 of group B rising from 37.1  4.0 to 42.4 
9.2 mm Hg (P>.05).
The indices were restored to normal about 30 minutes
after the second challenge (Figure 3, A-D). The RR of
group A declined to 13  3.8 breaths/min, and the RR
of group B to 19  5.5 breaths/min; the Ppeak of group
A was 10  3.9 cm H2O, and the Ppeak of group B 12
 3.4 cm H2O; the Cdyn of group A returned to 35.5 
7.7 mL/cm H2O, and the Cdyn of group B to 21  9.1686 The Journal of Thoracic and Cardiovascular SurgmL/cm H2O; the VT of group A went back to 21  9.1
mL/cm H2O, and the VT of group B to 270  87.3 mL.
Reduced Airway Inflammation After HSVHP
After the second challenge, dogs in group A showed a
dramatic decrease in inflammatory cells, including neutro-
phils, macrophages, and eosinophils, in the lungs and bron-
choalveolar lavage fluid relative to group B (Table 1). In
group A, the total cells, macrophages, neutrophils, lympho-
cytes, and eosinophils were 6.1  2.8, 3.6  1.9, 1.8  0.9,
0.6  0.4, and 0.01  0.02 106 cells/mL, whereas in group
B, they were 36.9  9.6, 26.2  8.0, 8.2  2.0, 1.3  0.5,
and 0.51  0.44 106 cells/mL. The differences between
the groups in the numbers of total cells, macrophages, neu-
trophils, lymphocytes, and eosinophils were statistically
significant (P<.05).
Impact of HSVHP on Circulating Proinflammatory
Markers
After the first challenge, IL-4 in group A in plasma
increased from 0.396  0.279 to 0.413  0.325 ng/L (P>
.05), and in group B it increased from 0.428  0.195 to
0.444 0.266 ng/L (P>.05; Table 2). Significant increasesery c August 2014
FIGURE 3. Five minutes after the second challenge, compared with indices 5 minutes before the challenge, respiratory rate (RR; A) and peak airway pres-
sure (Ppeak; B) showed no remarkable changes (P>.05) in group A; however, significant increases (P<.05) in both were observed in group B. A dramatic
decrease (P<.05) in dynamic compliance (Cdyn; C) was seen in group B, and no conspicuous change (P>.05) was found in group A. A descending trend
(P>.05) in tidal volume (VT; D) could been seen in group B, whereas an ascending trend (P>.05) was observed in group A. No significant change in PaO2
was found in group A, whereas in group B a dramatic drop (P<.05) in PaO2 (E) was observed. PaCO2 experienced no significant change in both groups
(P> .05) (F). The indices were restored to normal approximately 30 minutes after the second challenge (A-D). 5 MBC, 5 minutes before challenge;
5 MAC, 5 minutes after challenge; 30 MAC, 30 minutes after challenge.
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Sin IgE were observed in both groups (Table 2). IgE in group
A increased from 0.856  0.328 to 1.232  0.434 IU/mL
(P< .05), whereas IgE in group B increased from 1.040
 0.127 to 1.514  0.106 IU/mL (P<.05).
After the second challenge, the IL-4 of group A increased
from 0.412  0.311 to 0.514  0.450 ng/L (P > .05),
whereas the IL-4 of group B increased from 0.370 
0.236 to 0.581  0.357 ng/L (P>.05) (Table 2). A signifi-
cant increases in IgE was observed in group B, with the IgE
of group B increased from 0.660  0.093 to 0.972  0.238TABLE 1. The numbers of total cells and inflammatory cells in
bronchoalveolar lavage fluid
Types of cells Group A Group B
Total cells 6.1  2.8 36.9  9.6
Macrophages 3.6  1.9 26.2  8.0
Neutrophils 1.8  0.9 8.2  2.0
Lymphocytes 0.6  0.4 1.3  0.5
Eosinophils 0.01  0.02 0.51  0.44
Others 0.13  0.25 0.69  0.86
All figures represent mean  SD and are in 106 cells/mL. P<.05 for all comparisons
of numbers of inflammatory cells between groups A and B.
The Journal of Thoracic and CaIU/mL (P< .05). The IgE of group A was elevated from
0.586  0.109 to 0.994  0.282 IU/mL (P>.05), and there
was no significant difference in IgE between the groups
(Table 2).Influence of HSVHP on the Function of the Cardiac
Plexus
After HSVHP, no significant differences in HR and MAP
were observed in group A dogs relative to values before the
operation. The HR in group Awas 166  26.7 beats/min 5
minutes before the first challenge; after HSVHP and imme-
diately before the second challenge, the HR of group Awas
173  33.2 beats/min (P>.05). The MAP in group Awas
107 18.0 mmHg before the first challenge, and it dropped
to 93  16.9 mm Hg after the operation (P>.05).DISCUSSION
After the operation, dogs in group A showed digestive
symptoms including vomiting, with normal health restored
gradually 4 days later, whereas in group B no similar
symptoms were observed. The vomiting may have beenrdiovascular Surgery c Volume 148, Number 2 687
TABLE 2. Changes in inflammatory serummarkers before and after 2
challenge sessions
Group 5 min before challenge 5 min after challenge
First challenge
Interleukin 4 (ng/L)
A 0.396  0.279 0.413  0.325
B 0.428  0.195 0.444  0.266
IgE (IU/mL)
A 0.856  0.328 1.232  0.434*
B 1.040  0.127 1.514  0.106*
Second challenge
Interleukin 4 (ng/L)
A 0.412  0.311 0.514  0.450
B 0.370  0.236 0.581  0.357
IgE (IU/mL)
A 0.586  0.109 0.994  0.282
B 0.660  0.093 0.972  0.238*
All data are mean  SD. Comparisons were made between indices 5 minutes before
the challenge and those 5 minutes after the challenge. *P<.05.
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Sdue to the intraoperative stimulation of the vagal trunk. No
bronchorrhea was found in either group. On the other hand,
in group A bronchial submucous glands secreted less
mucus because of blockade of the parasympathetic nerve
pathway. No pneumothorax developed in either group,
and no significant changes in HR and MAP were observed
in group A after the operation relative to preoperative
values, suggesting that the vagal cardiac plexus was func-
tionally normal.
Airway hyperresponsiveness is the most striking feature
of asthma. In this study, the most commonly used indicators
of pulmonary function (RR, Ppeak, Cdyn, and VT16-19) were
used for the evaluation of airway hyperresponsiveness.
Airway hyperresponsiveness was induced by the first
aerosol inhalation of A suum antigen in both groups. After
the second challenge, no significant changes were observed
in RR, Ppeak, and Cdyn in group A, whereas dramatic
changes in RR, Ppeak, and Cdyn could still be observed in
group B. The results show that HSVHP protected the dogs
in group A from airway hyperresponsiveness.
Nonspecific chronic inflammation of the airway has
been seen as the pathologic basis of asthma.20-22 Some
investigations have suggested that the hyperreactivity of
the vagus nerve, in conjunction with certain immunologic
mechanisms, may produce proinflammatory chemical
mediators.9,23,24 In our study, the dogs treated by HSVHP
showed dramatic decreases in inflammatory cells in the
lungs and bronchoalveolar lavage; however, HSVHP had
no impact on serum proinflammatory markers. After the
second challenge, IL-4 in both groups increased, as it did af-
ter the first challenge. Although the serum IgE of group A
did not increase after the second challenge as significantly
as did the IgE of group B, an increasing trend was
observed and the underlying mechanism warrants further
investigation.688 The Journal of Thoracic and Cardiovascular SurgAccording to our results, the HSVHP worked the same
way as anticholinergic inhalers do. Both suppress asthma
by blocking the airway vagal pathway. HSVHP, however,
specifically inhibited the bronchial vagal reaction, so that
side effects such as dry mouth, which is especially common
in asthmatic patients receiving long-acting anticholinergic
agents, were avoided. Recently, bronchial thermoplasty
was reported to use heat generated by radiofrequency
energy to ablate smooth muscles and thereby relieve bron-
choconstriction.25 Consistent with this notion, HSVHP con-
trols bronchoconstriction by inhibiting enhanced vagal tone
that induces excessive contraction of airway smooth mus-
cles. Moreover, anatomic investigation demonstrated that
human vagal branches in the hilus pulmonis consists of
anterior branches, posterior branches, and superior
branches that were only found in some people. The bilateral
vagotomy is feasible in human beings, which suggests that
that it could become a new choice for the treatment of
asthma.
This study also had some limitations. The totally sedated
dogs were challenged through tracheal intubation, and
airway indices were also detected via tracheal intubation,
which may have affected the results of the determination
of airway parameters. In fact, it is very difficult to induce
asthma and measure airway indicators in awake dogs
without intubation. In our future studies, we will evaluate
the effect of HSVHP in terms of airway parameters on
awake patients with asthma without intubation.References
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